You are here

vaccines

Merck’s Zostavax draws new litigation from patients alleging they contracted shingles

Merck’s Zostavax draws new litigation from patients alleging they contracted shingles

Fierce Pharma

Flag link:

The flu vaccines are coming: GSK, Sanofi ship the first of more than 150M doses headed to U.S.

The flu vaccines are coming: GSK, Sanofi ship the first of more than 150M doses headed to U.S.

Fierce Pharma

Flag link:

Takeda relocates hundreds of R&D, vaccine staffers and cuts 480 in sales: report

Takeda relocates hundreds of R&D, vaccine staffers and cuts 480 in sales: report

Fierce Pharma

Flag link:

VBI Vaccines takes a shot at HBV Phase 3

VBI Vaccines takes a shot at HBV Phase 3

BioPharma Dive

Flag link:

HPV Infection Rates Plummet With Vaccination

HPV Infection Rates Plummet With Vaccination

Forbes

cervical cancer

Flag link:

Sanofi gets a flu vaccines booster with $650M-plus Protein Sciences buy

Sanofi gets a flu vaccines booster with $650M-plus Protein Sciences buy

Fierce Pharma

Protein Sciences

Flag link:

Forget Sanofi's Zika shot. A new measure would limit pricing on all DOD-funded medication

Forget Sanofi's Zika shot. A new measure would limit pricing on all DOD-funded medication

Fierce Pharma

Department of Defense

Flag link:

Personalized cancer vaccines vanquish melanoma in small but encouraging study

Personalized cancer vaccines vanquish melanoma in small but encouraging study

Stat

personalized medicine

Neon Therapeutics

Flag link:

Pain-free microneedle patch could help boost flu vaccination rates

Pain-free microneedle patch could help boost flu vaccination rates

Fierce Pharma

Micron Biomedical

Flag link:

Senators lay into Sanofi for Zika vaccine deal, call for public hearing

Senators lay into Sanofi for Zika vaccine deal, call for public hearing

Fierce Pharma

Flag link:

Eyeing a $6B market, Bavarian Nordic posts positive phase 2 data for universal RSV vaccine

Eyeing a $6B market, Bavarian Nordic posts positive phase 2 data for universal RSV vaccine

Fierce Pharma

Bavarian Nordic

clinical trials

Flag link:

AstraZeneca's struggling FluMist loses out on crucial CDC vaccine backing—again

AstraZeneca's struggling FluMist loses out on crucial CDC vaccine backing—again

Fierce Pharma

Flag link:

GSK’s Bexsero, Shingrix to pass $1B sales mark by 2022: report

GSK’s Bexsero, Shingrix to pass $1B sales mark by 2022: report

Fierce Pharma

Flag link:

Pfizer kicks off human testing with maternal GBS vaccine

Pfizer kicks off human testing with maternal GBS vaccine

Fierce Pharma

Flag link:

Pfizer Begins Phase 1 Clinical Trial to Evaluate Investigational Group B Streptococcus Vaccine

Pfizer Begins Phase 1 Clinical Trial to Evaluate Investigational Group B Streptococcus Vaccine

Businesswire

clinical trials

Flag link:

Merck CEO: Gardasil plus pipeline equals big things ahead for vaccines

Merck CEO: Gardasil plus pipeline equals big things ahead for vaccines

Fierce Pharma

Moderna Therapeutics

Flag link:

ASCO: Dendreon touts T-cell response data for prostate cancer vaccine Provenge

ASCO: Dendreon touts T-cell response data for prostate cancer vaccine Provenge

Fierce Pharma

prostate cancer

Flag link:

Pfizer’s Trumenba to challenge GlaxoSmithKline's Bexsero with EU nod

Pfizer’s Trumenba to challenge GlaxoSmithKline's Bexsero with EU nod

Fierce Pharma

meningococcal B

Flag link:

Merck's experimental Ebola vaccine poised for emergency use in Congo outbreak

Merck's experimental Ebola vaccine poised for emergency use in Congo outbreak

Fierce Pharma

Flag link:

New study could boost vaccination argument for Merck's Gardasil

New study could boost vaccination argument for Merck's Gardasil

Fierce Pharma

Flag link: